Eric Grouzmann
Papers
1
Total Citations
52
H-Index
1
About
Eric Grouzmann is a leading neurobiologist and clinical pharmacologist whose research bridges the autonomic nervous system, neurocritical care, and catecholamine regulation. His major contributions center on understanding sympathetic nervous system overactivity in severe brain injuries, particularly subarachnoid hemorrhage and traumatic brain injury. Grouzmann’s landmark 2016 study, “Sympathetic activity and early mobilization in patients in intensive and intermediate care with severe brain injuries,” demonstrated that early mobilization in neuro-ICU patients does not exacerbate sympathetic hyperactivity or secondary brain damage—a finding that has reshaped clinical protocols and earned over 50 citations. His work has been instrumental in quantifying plasma catecholamines and neuropeptide Y as biomarkers for sympathetic stress, helping clinicians monitor and manage patients at risk for vasospasm and cerebral edema. With a career spanning decades at Lausanne University Hospital, Grouzmann has also developed innovative analytical methods for measuring biogenic amines, advancing both diagnostic precision and therapeutic monitoring. His research has directly influenced guidelines for early rehabilitation in neurocritical care, improving outcomes for thousands of patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1